Radiation Oncology/Therapy: Page 69

Elekta, Varian bury the hatchet
By AuntMinnieEurope.com staff writers
Radiation oncology firm Elekta and radiation therapy firm Varian Medical Systems have resolved their litigation announced in August 2012.
August 14, 2013
How molecular techniques can transform abdominal oncology
By Philip Ward
Molecular imaging is enhancing assessment of therapy response and facilitating risk-adapted, personalized therapy in malignancies. Moreover, research on exploiting the specific molecular features of tumors can translate into better clinical care.
August 11, 2013
2013 08 09 12 55 01 360 2013 08 12 Abdo Oncology Thumv
U.K. invests in proton therapy
By AuntMinnieEurope.com staff writers
The U.K. has committed 250 million pounds (291 million euros) to build two new state-of-the-art proton therapy centers.
August 8, 2013
Elekta wins Danish contract
By AuntMinnieEurope.com staff writers
Radiation oncology firm Elekta has won a contract with a Danish hospital for its Versa HD linear accelerator, the company said.
July 23, 2013
RaySearch unveils new RayStation
By AuntMinnieEurope.com staff writers
Radiation therapy planning software firm RaySearch has introduced version 4.0 of its RayStation treatment planning system.
July 22, 2013
Eckert & Ziegler invests in Chinese-German joint venture
By AuntMinnieEurope.com staff writers
Radiotherapy developer Eckert & Ziegler will acquire a minority interest in a Chinese-German radiopharmaceuticals joint venture.
July 22, 2013
Elekta gets CE Mark for prostate motion monitoring
By AuntMinnieEurope.com staff writers
Radiation oncology firm Elekta has received a CE Mark for its Clarity 4D monitoring system.
July 18, 2013
MRI method images glucose uptake in vivo
By Tami Freeman, PhD
Altered glucose metabolism is associated with a range of pathological conditions. In particular, solid tumors have more glucose consumption compared with healthy tissue -- a feature that can be used for tumor detection, monitoring disease progression, and evaluating therapy response, U.K. researchers found.
July 17, 2013
2013 07 17 12 54 28 592 2013 07 17 Mri Glucocest 18july13 20130717201904
3D volumetry methods can boost therapy response assessment
By Erik L. Ridley
Oncologists need more information from radiologists to improve assessment of treatment response, and 3D volumetry techniques can be ideal for this purpose, yielding precise and invaluable prognostic information such as early tumor shrinkage, according to Dr. Anno Graser.
July 16, 2013
2013 07 17 11 15 29 535 2013 07 17 Recist Pic1 20130717181819
Support gathers for Swiss radioimmunotherapy study
By AuntMinnieEurope.com staff writers
The Society of Nuclear Medicine and Molecular Imaging is highlighting a Journal of Nuclear Medicine study that suggests a new radioimmunotherapy treatment option is safe and feasible for patients with relapsing follicular, mantle cell, and other indolent B-cell lymphomas.
July 15, 2013
SCoR: Radiotherapy training has serious attrition problem
By AuntMinnieEurope.com staff writers
The U.K. Society and College of Radiographers (SCoR) has published a report that found more than a third of radiotherapy students fail to complete their training.
July 14, 2013
European interventional oncology market evolves
By AuntMinnieEurope.com staff writers
Driven by its cost-effectiveness and ability to provide improvement in quality of life, interventional oncology is growing in popularity in Europe, and the specialty is rapidly evolving, according to a new report from market research firm Frost & Sullivan.
July 9, 2013
Previous Page
Page 69 of 126
Next Page